198 related articles for article (PubMed ID: 12528307)
1. Third generation thrombolytics for the treatment of ischemic stroke.
Qureshi AI; Pande RU; Kim SH; Hanel RA; Kirmani JF; Yahia AM
Curr Opin Investig Drugs; 2002 Dec; 3(12):1729-32. PubMed ID: 12528307
[TBL] [Abstract][Full Text] [Related]
2. Recanalization and reperfusion therapies for acute ischemic stroke.
Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
[TBL] [Abstract][Full Text] [Related]
3. Technology Insight: recanalization with drugs and devices during acute ischemic stroke.
Smith WS
Nat Clin Pract Neurol; 2007 Jan; 3(1):45-53. PubMed ID: 17205074
[TBL] [Abstract][Full Text] [Related]
4. Neuroendovascular management of acute ischemic stroke.
Tjoumakaris SI; Jabbour PM; Rosenwasser RH
Neurosurg Clin N Am; 2009 Oct; 20(4):419-29. PubMed ID: 19853801
[TBL] [Abstract][Full Text] [Related]
5. Alteplase for acute ischemic stroke.
Gonzales NR; Grotta JC
Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound enhanced thrombolysis in acute arterial ischemia.
Tsivgoulis G; Culp WC; Alexandrov AV
Ultrasonics; 2008 Aug; 48(4):303-11. PubMed ID: 18511094
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
[TBL] [Abstract][Full Text] [Related]
8. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
Köhrmann M; Schellinger PD; Schwab S
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
[TBL] [Abstract][Full Text] [Related]
9. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
California Acute Stroke Pilot Registry (CASPR) Investigators
Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
11. Advances in revascularization for acute ischemic stroke treatment: an update.
Eesa M; Schumacher HC; Higashida RT; Meyers PM
Expert Rev Neurother; 2011 Aug; 11(8):1125-39. PubMed ID: 21797654
[TBL] [Abstract][Full Text] [Related]
12. Why are eligible thrombolysis candidates left untreated?
Hills NK; Johnston SC
Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
Jahan R; Vinuela F
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches.
Pettersen JA; Hudon ME; Hill MD
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):285-99. PubMed ID: 15151476
[TBL] [Abstract][Full Text] [Related]
15. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
16. Advances in revascularization for acute ischemic stroke treatment.
Schumacher HC; Gupta R; Higashida RT; Meyers PM
Expert Rev Neurother; 2005 Mar; 5(2):189-201. PubMed ID: 15853489
[TBL] [Abstract][Full Text] [Related]
17. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
Qureshi AI; Kirmani JF; Sayed MA; Safdar A; Ahmed S; Ferguson R; Hershey LA; Qazi KJ;
Neurology; 2005 Jun; 64(12):2115-20. PubMed ID: 15985583
[TBL] [Abstract][Full Text] [Related]
18. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients.
Brouns R; Heylen E; Sheorajpanday R; Willemse JL; Kunnen J; De Surgeloose D; Hendriks DF; De Deyn PP
Clin Neurol Neurosurg; 2009 Feb; 111(2):165-70. PubMed ID: 18980797
[TBL] [Abstract][Full Text] [Related]
19. [Indications for thrombolytics].
Charbonnier B
Rev Prat; 1999 Oct; 49(15):1659-63. PubMed ID: 10581997
[TBL] [Abstract][Full Text] [Related]
20. Interventional stroke therapy: the potential benefit of direct intra-arterial infusion.
Connors JJ
Rev Cardiovasc Med; 2002; 3 Suppl 2():S92-9. PubMed ID: 12556748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
